ro co tirzepatide Eli Lilly strikes Zepbound deal with Ro, amid questions on compounded GLP-1s Ro Partners with Lilly to

Diabetes itself is the most common cause of peripheral neuropathy in the UK, with approximately 50% of people with long-standing diabetes developing some degree of nerve damage independent of weight management medications

Prioritize Healthy Sleep Sleep is one of the most overlooked aspects of metabolic health

Metabolic and Neurological Applications Research into melanocortin pathways indicates potential in treating early-onset obesity and metabolic syndrome linked to MC4R mutations (5)

For more information on the analysis and sources, refer to the Methodology section

Cochrane.Database.Syst Rev 2005;(1):CD002779

Induced pluripotent stem cells in disease modelling and drug discovery